PDA

View Full Version : Medical Articles and Abstracts


Pages : 1 2 [3] 4

  1. Abstract Links/List - Other
  2. Abstract Links/List - Vascular surgery
  3. Abstract Links/List - Urologic surgery
  4. Abstract Links/List - Trauma
  5. Abstracts Links/List - Transplants
  6. Abstracts Links/List - Transfusion strategies
  7. Abstract Links/List - Transfusion issues
  8. Abstracts Links/List - Thrombopoietin
  9. Abstract Links/List - Thoracic surgery
  10. Abstract Links/List - Thermal injury
  11. Abstract Links/List - Preterm infant
  12. Abstract Links/List - Orthopedic surgery
  13. Abstract Links/List - Oncology
  14. Abstract Links/List - Normovolemic hemodilution
  15. Abstract Links/List - Neurosurgery
  16. Abstract Links/List - Laparoscopic surgery
  17. Abstract Links/List - Interventional radiology
  18. Abtracts Links/List - Hyperbaric oxygen therapy
  19. Abstracts Links/List - Hypotensive anesthesia
  20. Leukocyte filtration and miniature perfusion during arrested heart CABG on a Jehovah'
  21. Abstract Links/List - Hypothermia
  22. Abstract Links/List - Hematological diseases
  23. Abstract Links/List - Head and neck surgery
  24. Abstract Links/List - Gynecologic surgery
  25. Abstract Links/List - General Surgery
  26. Abstract Links/List - Erythropoietin
  27. Abstract Links/List - Coagulants
  28. Abstract Links/List - Cardiac surgery
  29. Abstract Links/List - Blood substitutes
  30. Abstracts Links/List - Blood salvage
  31. Abstract Links/List - Anesthesiology
  32. Influence of body core temperature on blood loss and transfusion requirements during
  33. Transfusion-related acute lung injury following allogeneic bone marrow transplantatio
  34. Allogenic blood transfusion in the first 24 hours after trauma is associated with inc
  35. Recombinant Human Coagulation Factor VIIa in Jehovah's Witness Patients Liver Transpl
  36. Laparoscopic nephrectomy for autosomal dominant polycystic kidney disease.
  37. Acute lung injury after blood transfusion in mechanically ventilated patients
  38. Erythropoietin is an effective clinical modality for reducing RBC transfusion in join
  39. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's W
  40. To Do or Not to Do Living Donor Hepatectomy in Jehovah's Witnesses: Single Institutio
  41. Orthopedic Blood Avoidance
  42. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A sy
  43. Perioperative blood transfusion and survival following curative hepatic resection for
  44. The Search for a Blood Substitute
  45. Endovascular Stent Grafting for Thoracic Aneurysms in Jehovah's Witnesses: Report of
  46. Undiagnosed anemia common with chronic illness
  47. Cell Salvage in Obstetrics - Is It Time?
  48. Erythropoietin and Iron
  49. Anemia in Patients With Cancer or Undergoing Cancer Therapy: Impact and Current Treat
  50. Anemia and Blood Transfusion in the Critically Ill Patient
  51. The Limits of Bloodless Surgery
  52. Tolerance of Acute Anemia: The Anesthesiology Perspective
  53. Relationship of blood transfusion and clinical outcomes in patients with acute corona
  54. Toward an understanding of transfusion-related acute lung injury: statement of a cons
  55. Joint ASH and AABB educational session
  56. The risks of blood transfusions and the shortage of supply leads to the quest for blo
  57. Extreme Intraoperative Blood Loss and Hemodilution in a Jehovah's Witness: New Aspect
  58. The use of recombinant factor VIIa for bleeding in paediatric practice.
  59. The use of activated recombinant coagulation factor VII during haemarthroses and syno
  60. Cost implications of post-surgical morbidity following blood transfusion in cancer pa
  61. [Endoscopic extraperitoneal radical prostatectomy. Results after 300 procedures]
  62. Maternal blood loss by expansion of uterine incision at caesarean section--a comparis
  63. Impact of surgical era on outcomes of patients undergoing elective atherosclerotic as
  64. Surgical management of severe obstetric hemorrhage: experience with an obstetric hemo
  65. [Supplemental survey in 2003 concerning life-threatening hemorrhagic events in the op
  66. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of flui
  67. Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-d
  68. How to approach major surgery where patients refuse blood transfusion
  69. Erythropoietin use in a pregnant Jehovah's witness with anemia and beta-thalassemia:
  70. Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients wit
  71. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous
  72. Bench-to-bedside review: iron metabolism in critically ill patients.
  73. The theory and practice of bloodless surgery
  74. Hyperoxia in extreme hemodilution.
  75. Influence of storage on red blood cell rheological properties.
  76. Comparative Effects of Red Blood Cell Transfusion and Increasing Blood Flow on Tissue
  77. Hematocrit value on intensive care unit entry influences thefrequency of q-wave myoca
  78. Chronic myeloproliferative disorders.
  79. Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin
  80. Bone marrow transplantation.
  81. Quality of red blood cells using the Dideco Electa autotransfusion device
  82. Combination of acute preoperative plateletpheresis, cell salvage, and aprotinin minim
  83. The erythropoietin-receptor pathway modulates survival of cancer cells
  84. Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated
  85. A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for
  86. Prior red blood cell transfusions in cancer patients increase the risk of subsequent
  87. Anemia in patients on combined androgen block therapy for prostate cancer
  88. Emerging infectious threats to the blood supply
  89. An analysis of 55 patients concerning the significance of ductal and radial margins
  90. application of hyperbaric oxygen in the treatment of severe anemia
  91. activated recombinant factor VII for intractable hemorrhage after cardiovascular surg
  92. Blood Collection and Transfusion in the United States in 1999
  93. Cell Salvage in Obstetrics: The Time Is Now
  94. Recombinant human erythropoietin therapy in low-birthweight preterm infants
  95. Efficacy and cost effectiveness of harmonic scalpel compared with electrocautery
  96. Blood Transfusion in Patients With Acute Coronary Syndrome
  97. Strict red blood cell transfusion guideline reduces the need for transfusions in.....
  98. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recomb
  99. Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-ex
  100. Blood Transfusion Predicts Mortality in Patients with Blunt Spleen and Liver Injuries
  101. Treatment of Life-Threatening Hemorrhage Following Blunt Trauma: The Role of Recombin
  102. Haemovigilance in a general university hospital: need for a more comprehensive classi
  103. Strategies to optimize the use of erythropoietin and iron therapy in oncology patient
  104. The effect of aprotinin on blood loss in bilateral total knee arthroplasty
  105. Number needed to treat and cost of recombinant human erythropoietin to avoid one tran
  106. The safety and efficacy of "bloodless" cardiac surgery
  107. Blood conservation and the management of perioperative blood transfusions in a patien
  108. Alternatives to blood in the 21st century
  109. Immunologic mechanisms of EPO-associated pure red cell aplasia.
  110. Clinical characteristics of erythropoietin-associated pure red cell aplasia
  111. Safety and efficacy of superselective angioembolization in control of lower gastroint
  112. Phase III clinical trials with darbepoetin: implications for clinicians.
  113. FDA Drug Approval Summary: Azacitidine (5-azacytidine, VidazaTM) for Injectable Suspe
  114. Prognostic factors of surgical resection in middle and distal bile duct cancer: An an
  115. A systematic review of the application of hyperbaric oxygen in the treatment of sever
  116. Early experience with activated recombinant factor VII for intractable hemorrhage aft
  117. Recommended practices for endoscopic minimally invasive surgery
  118. Recommended practices for electrosurgery.(Recommended Practices)
  119. The Robot Is In -- And Ready to Operate
  120. Autologous Stem-Cell Transplantation Can Be Performed Safely Without the Use of Blood
  121. Emerging Infectious Threats to the Blood Supply
  122. Beneficial effect of acute normovolemic hemodilution in cardiovascular surgery
  123. A survey of autologous blood transfusion practices in Germany
  124. Cardiovascular response to acute normovolemic hemodilution in patients with coronary
  125. Two injections of erythropoietin correct moderate anemia in most patients awaiting or
  126. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic dis
  127. An Approach to Anemia in Critically Ill Patients: Transfusion or Tolerance?
  128. Blood transfusion and pulmonary lipid peroxidation in ventilated premature babies
  129. Relationship of blood transfusion and clinical outcomes in patients with acute corona
  130. Blood transfusion is associated with donor leukocyte microchimerism in trauma patient
  131. Commentary: Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary S
  132. Modified extrapleural ligation of patent ductus arteriosus: a convenient surgical app
  133. Laparoscopic restorative proctocolectomy
  134. Efficacy and cost effectiveness of harmonic scalpel compared with electrocautery in p
  135. Transfusion-free pediatric burn surgery: techniques and strategies
  136. Targeted Oxygen Delivery: A New Alternative to Red Cell Transfusion
  137. Modern concepts of autologous haemotherapy
  138. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality fo
  139. Allogeneic transfusion and infection: economic and clinical implications
  140. Association of ABO-mismatched platelet transfusions with morbidity/mortality
  141. Anemia and blood transfusion in critically ill patients
  142. Bacterial contamination of blood components: risks, strategies, and regulation
  143. Blood replacement in elective surgery: results of the Sanguis Study
  144. Forty Years of Clinical Aprotinin Use: A Review of 124 Hypersensitivity Reactions
  145. Modified extrapleural ligation of patent ductus arteriosus: a convenient surgical app
  146. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated wit
  147. Role of parenteral iron in the management of anaemia in the elderly patient undergoin
  148. Tranexamic Acid Reduces Intraoperative Blood Loss in Pediatric Patients Undergoing Sc
  149. Recommended practices for endoscopic minimally invasive surgery
  150. Medical hemostasis in experimental liver resection with antifibrinolytic therapy
  151. A 44-year-old Jehovah's Witness with life-threatening anemia from uterine bleeding
  152. Transfusion-related acute lung injury
  153. Transfusion-related acute lung injury
  154. Blood transfusion associated fatalities
  155. Intraoperative blood salvage: fluid replacement calculations
  156. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage
  157. Blood transfusion is an independent predictor of increased mortality
  158. rHuEpo before high-dose therapy allows autologous peripheral stem-cell transp
  159. Recombinant erythropoietin in clinical practice
  160. The Role of Recombinant Human Erythropoietin in the Treatment of Thalassemia
  161. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill
  162. Drug for hemophiliacs may help stroke victims
  163. Antifibrinolytic agents in traumatic haemorrhage
  164. Development and implementation of a bloodless medicine and surgery program.
  165. The Public Health Impact Of Prion Diseases
  166. Objectives of a bloodless surgery program
  167. Blood conservation in total joint arthroplasty: blood as a drug
  168. Prevalence and outcomes of anemia in surgery: a systematic review of the literature
  169. Comparative Effects of Red Blood Cell Transfusion and Increasing Blood Flow on Tissue
  170. Leukocyte filtration and miniature perfusion arrested heart CABG Jehovah's Witness
  171. Long-term Use of Hydroxyurea for Sickle Cell Anemia
  172. Autologous blood procurement--acute normovolemic hemodilution vs. PAD
  173. Ordering blood for the wrong patient--getting inside the minds of ordering physicians
  174. Determinants of hospital mortality of adult recipients of right lobe live donor liver
  175. Risks of blood transfusion
  176. Emerging risks and outcomes of blood transfusion in surgery
  177. Blood transfusion risks in the intensive care unit
  178. Surgery and transfusion in Jehovah's witness patient. Medical legal review
  179. Live donor liver transplantation without blood products: strategies developed for JWs
  180. Jehovah's Witnesses requiring complex urgent cardiothoracic surgery
  181. Cell salvage in obstetrics: leucocyte depletion filtration to remove amniotic fluid
  182. Two cases of severe postpartum anaemia in Jehovah's witnesses
  183. Responses by pregnant Jehovah's Witnesses on health care proxies
  184. Pre-myomectomy uterine artery embolisation minimises operative blood loss
  185. Fewer Blood Transfusions May be Linked to Reduced Stroke Risk
  186. Great Website for Cardiac Surgeons
  187. Evaluating and Treating Active Patients for Anemia
  188. Anemia is an independent predictor of mortality after percutaneous coronary
  189. Jehovah's witnesses requiring complex urgent cardiothoracic surgery
  190. Oxygen Transport and Delivery
  191. The Transfusion Trigger - Indications for Red Cell Therapy
  192. The Physiology of Oxygen Delivery
  193. New Trends in Oxygen Delivery, Consumption and Debt Assessment: Global and Regional I
  194. New Trends in Oxygen Delivery, Consumption and Debt Assessment: Global and Regional
  195. Allogeneic Transfusion vs Alternatives - Costs
  196. Does a perception of increased blood safety mean increased blood transfusion? An asse
  197. Does a perception of increased blood safety mean increased blood transfusion? An asse
  198. Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination
  199. Autologous transfusion techniques: a systematic review of their efficacy
  200. Window-period human immunodeficiency virus transmission to two recipients by an adole
  201. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release
  202. Low-dose oral vitamin K is safe and effective for outpatient management of INR>10
  203. Hb content-based transfusion policy successfully reduces RBC units transfused
  204. Transfusion Trigger?
  205. Perioperative Blood Transfusion Is Predictive of Poststernotomy Surgical Site Infect
  206. Effect of flow chart on blood transfusions in TJR prospective before and after
  207. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron p
  208. Survival after transfusion as assessed in a large multistate US cohort
  209. Trauma-care revolution among benefits touted as blood substitute enters critical phas
  210. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban
  211. Epoetin Use for Anemia in Chronic Renal Failure
  212. Epoetin Use for Anemia in Oncology
  213. Recombinant factor VIIa prophylaxis in patient severe congenital factor VII deficienc
  214. Successful CABG in a patient with paroxysmal nocturnal hemoglobinuria
  215. Effective and safe use of recombinant factor VIIa in elderly mild haemophilia A
  216. Predictive value of megakaryocytic and erythroid colony formation/platelet function
  217. predictive value of megakaryocytic and erythroid colony formation/platelet function
  218. Effective and safe use of recombinant factor VIIa in elderly mild haemophilia A
  219. Effective and safe use of recombinant factor VIIa in elderly mild haemophilia
  220. Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience
  221. Thalidomide for treatment of severe intestinal bleeding
  222. Thalidomide for treatment of severe intestinal bleeding
  223. Clopidogrel-Plavix does not increase bleeding and allogenic blood transfusion in CABG
  224. Clopidogrel does not increase bleeding and allogenic blood transfusion in CABG
  225. Clopidogrel-Plavix does not increase bleeding and allogenic blood transfusion in CABG
  226. Selection of Abstracts on Treating Anemia
  227. Recombinant Factor VIIa for severe surgical liver bleeding in 5 month old baby
  228. Blood Transfusion Poses CJD Risk - News From Lancet
  229. Recombinant FVIIa in the management of uncontrolled hemorrhage.
  230. Patients with impending abdominal compartment syndrome do not respond to early volume
  231. Factors involved in gastrointestinal bleeding in advanced cancer patients followed at
  232. Validation of a transfusion prediction model in head and neck cancer surgery
  233. Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery d
  234. Does manual removal of the placenta affect operative blood loss during cesarean sect
  235. Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after
  236. Autoantibody formation after alloimmunization: are blood transfusions a risk factor f
  237. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood prod
  238. Clinical factors associated with an increased risk of perioperative blood transfusion
  239. Operative blood loss and use of blood products after laparoscopic and conventional op
  240. Does blood transfusion increase risk of postoperative complications?
  241. Primary OPCAB as a Strategy for Acute Coronary Syndrome and Acute Myocardial Infarcti
  242. Risks of blood transfusion
  243. Blood conservation in the intensive care unit
  244. Transfusion medicine : support of patients undergoing cardiac surgery
  245. he effect of aspirin on blood loss and transfusion requirements in patients with femo
  246. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in pati
  247. Blood conservation in primary total hip arthroplasty
  248. Blood conservation strategies in Jehovah's Witness patients undergoing complex aortic
  249. Cardiac-effect of preoperative antiplatelet/anticoagulant prophylaxis postop bleeding
  250. Surgery without blood - Shander